Effects of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate on cortical and trabecular bone of vertebra and proximal femur in postmenopausal women with fragility fracture: Sub-analysis by quantitative computed tomography from the TERABIT study

Ryosuke Takahashi; Ko Chiba; Narihiro Okazaki; Makoto Era; Kazuaki Yokota; Yoshihiro Yabe; Choko Kondo; Toru Fukuda; Kaisho Fukushima; Mika Kono; Yasue Michikoshi; Shuta Yamada; Takeshi Iida; Kazutaka Mitsumizo; Shuntaro Sato; Mitsuru Doi; Kounosuke Watanabe; Shingo Ota; Kazuteru Shiraishi; Akihiko Yonekura; Makoto Osaki

doi:10.1016/j.bone.2024.117189

Abstract

The effects of daily teriparatide (D-PTH, 20 μg/day), weekly high-dose teriparatide (W-PTH, 56.5 μg/week), or bisphosphonate (BP) on the vertebra and proximal femur were investigated using quantitative computed tomography (QCT).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Takahashi et al. (2024) studied this question.

synapsesocial.com/papers/68e61a64b6db6435875ace2a https://doi.org/10.1016/j.bone.2024.117189

View Full Paper

Ask AI

Bookmark

Share

Effects of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate on cortical and trabecular bone of vertebra and proximal femur in postmenopausal women with fragility fracture: Sub-analysis by quantitative computed tomography from the TERABIT study

Abstract

Discussion

Cite This Study

Effects of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate on cortical and trabecular bone of vertebra and proximal femur in postmenopausal women with fragility fracture: Sub-analysis by quantitative computed tomography from the TERABIT study

Abstract

Discussion

Cite This Study

Keep reading

Keep reading